Interferon for Older Patients with Hepatitis C?
IFN therapy was associated with improved survival and reduced risk for hepatocellular carcinoma in those with initial platelet counts <150,000 mm3.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)